NAV

ORG-25935

This drug entry is astuband has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
ORG-25935
DrugBank Accession Number
DB12220
Background

Org 25935 has been used in trials studying the treatment of Alcoholism, Schizophrenia, and Panic Disorder.

Type
Small Molecule
Groups
Investigational
Structure
 3D
Similar Structures
Weight
Average: 339.435
Monoisotopic: 339.183443669
Chemical Formula
C21H25NO3
Synonyms
Not Available
External IDs
  • ORG 25935
  • SCH 900435
  • SCH-900435

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
从超过世界人口访问药物产品信息l regions.
Access now
Product Ingredients
Ingredient UNII CAS InChI Key
Org 25935 Hydrochloride H6MSM69SSM 1146978-08-6 SDTLOODMXMDJFX-JKSHRDEXSA-N

Categories

Drug Categories
Chemical TaxonomyProvided byClassyfire
Description
This compound belongs to the class of organic compounds known as tetralins. These are polycyclic aromatic compounds containing a tetralin moiety, which consists of a benzene fused to a cyclohexane.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Tetralins
Sub Class
Not Available
Direct Parent
Tetralins
Alternative Parents
Alpha amino acids/Anisoles/Aralkylamines/Alkyl aryl ethers/Benzene and substituted derivatives/Trialkylamines/Amino acids/Monocarboxylic acids and derivatives/Carboxylic acids/Organic oxides
show 2 more
Substituents
Alkyl aryl ether/Alpha-amino acid/Alpha-amino acid or derivatives/Amine/Amino acid/Amino acid or derivatives/Anisole/Aralkylamine/Aromatic homopolycyclic compound/Carbonyl group
show 15 more
Molecular Framework
Aromatic homopolycyclic compounds
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
55L20667O4
CAS number
1147011-84-4
InChI Key
UEBBYLJZCHTLEG-UTKZUKDTSA-N
InChI
InChI=1S/C21H25NO3/c1-22(14-20(23)24)13-17-9-8-16-12-18(25-2)10-11-19(16)21(17)15-6-4-3-5-7-15/h3-7,10-12,17,21H,8-9,13-14H2,1-2H3,(H,23,24)/t17-,21+/m1/s1
IUPAC Name
2-({[(1R,2S)-6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-yl]methyl}(methyl)amino)acetic acid
SMILES
COC1=CC=C2[C@H]([C@@H](CN(C)CC(O)=O)CCC2=C1)C1=CC=CC=C1

References

General References
Not Available
PubChem Compound
11717074
PubChem Substance
347828499
ChemSpider
9891795
ZINC
ZINC000034640491
Wikipedia
ORG-25935

Clinical Trials

Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
2 Completed Treatment Schizophrenia 1
2 Terminated Treatment Alcohol Dependency 1
2 Terminated Treatment Panic Disorder 1
2 Withdrawn Treatment Schizophrenia 1
1 Completed Basic Science Healthy Subjects (HS) 1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Property Value Source
Water Solubility 0.00924 mg/mL ALOGPS
logP 3.87 ALOGPS
logP 1.07 Chemaxon
logS -4.6 ALOGPS
pKa (Strongest Acidic) 1.68 Chemaxon
pKa (Strongest Basic) 10.59 Chemaxon
Physiological Charge 0 Chemaxon
Hydrogen Acceptor Count 4 Chemaxon
Hydrogen Donor Count 1 Chemaxon
Polar Surface Area 49.77 Å2 Chemaxon
Rotatable Bond Count 6 Chemaxon
Refractivity 98.86 m3·mol-1 Chemaxon
Polarizability 37.57 Å3 Chemaxon
Number of Rings 3 Chemaxon
Bioavailability 1 Chemaxon
Rule of Five Yes Chemaxon
Ghose Filter Yes Chemaxon
Veber's Rule No Chemaxon
MDDR-like Rule Yes Chemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Spectrum Spectrum Type Splash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available

Drug created at October 20, 2016 21:38 / Updated at June 12, 2020 16:53